Evidence for RNA or protein transport from somatic tissues to the male reproductive tract in mouse

  1. Vera RInaldi
  2. Kathleen Messemer
  3. Kathleen Desevin
  4. Fengyun Sun
  5. Bethany C Berry
  6. Shweta Kukreja
  7. Andrew R Tapper
  8. Amy J Wagers
  9. Oliver J Rando  Is a corresponding author
  1. University of Massachusetts Medical School, United States
  2. Joslin Diabetes Center, United States
  3. Harvard University, United States

Abstract

The development of tools to manipulate the mouse genome, including knockout and transgenic technology, has revolutionized our ability to explore gene function in mammals. Moreover, for genes that are expressed in multiple tissues or at multiple stages of development, the use of tissue-specific expression of the Cre recombinase allows gene function to be perturbed in specific cell types and/or at specific times. However, it is well known that putative tissue-specific promoters often drive unanticipated 'off target' expression. In our efforts to explore the biology of the male reproductive tract, we unexpectedly found that expression of Cre in the central nervous system resulted in recombination in the epididymis, a tissue where sperm mature for ~1-2 weeks following the completion of testicular development. Remarkably, we not only observed reporter expression in the epididymis when Cre expression was driven from neuron-specific transgenes, but also when Cre expression in the brain was induced from an AAV vector carrying a Cre expression construct. A surprisingly wide range of Cre drivers - including six different neuronal promoters as well as the adipose-specific Adipoq Cre promoter - exhibited off target recombination in the epididymis, with a subset of drivers also exhibiting unexpected activity in other tissues such as the reproductive accessory glands. Using a combination of parabiosis and serum transfer experiments, we find evidence supporting the hypothesis that Cre may be trafficked from its cell of origin to the epididymis through the circulatory system. Together, our findings should motivate extreme caution when interpreting conditional alleles, and suggest the exciting possibility of inter-tissue RNA or protein trafficking in modulation of reproductive biology.

Data availability

A representative subset of the raw image data (with supporting metadata) will be made publicly available on acceptance. Source data for gels/blots has been provided.

Article and author information

Author details

  1. Vera RInaldi

    Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  2. Kathleen Messemer

    Section on Islet Cell and Regenerative Biology, Joslin Diabetes Center, Boston, United States
    Competing interests
    No competing interests declared.
  3. Kathleen Desevin

    Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  4. Fengyun Sun

    Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  5. Bethany C Berry

    Department of Biochemistry and Molecular Biotechnology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  6. Shweta Kukreja

    Department of BiochemisDepartment of Biochemistry and Molecular Biotechnologytry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  7. Andrew R Tapper

    Department of Neurobiology, University of Massachusetts Medical School, Worcester, United States
    Competing interests
    No competing interests declared.
  8. Amy J Wagers

    Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, United States
    Competing interests
    Amy J Wagers, is a scientific advisor for Kate Therapeutics and Frequency Therapeutics and a cofounder, advisor, and holder of private equity in Elevian, Inc., which also provides sponsored research to the Wagers Lab. Is a co-inventor on patents that include the use of AAVs for research and therapeutic applications (application numbers: 17/614,327, 63/332,655, 17/743,444, 63/344,328, 63/388,920)..
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0002-0066-0485
  9. Oliver J Rando

    Department of Biochemistry and Molecular Pharmacology, University of Massachusetts Medical School, Worcester, United States
    For correspondence
    Oliver.Rando@umassmed.edu
    Competing interests
    No competing interests declared.
    ORCID icon "This ORCID iD identifies the author of this article:" 0000-0003-1516-9397

Funding

Templeton World Charity Foundation (61350)

  • Vera RInaldi
  • Bethany C Berry
  • Shweta Kukreja
  • Oliver J Rando

National Institutes of Health (R01HD080224)

  • Kathleen Desevin
  • Fengyun Sun
  • Oliver J Rando

National Institutes of Health (R01DA047678)

  • Andrew R Tapper

National Institutes of Health (DP1AG063419)

  • Kathleen Messemer
  • Amy J Wagers

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Reviewing Editor

  1. Brett Nixon

Ethics

Animal experimentation: All animal use was approved by the Institutional Animal Care and Use Committees of UMass Chan Medical School and Harvard Faculty of Arts and Sciences, under protocol PROTO202100029 to Dr. Oliver Rando and protocol 29014 awarded to Dr. Amy Wagers.

Version history

  1. Received: February 9, 2022
  2. Preprint posted: February 10, 2022 (view preprint)
  3. Accepted: March 14, 2023
  4. Accepted Manuscript published: March 27, 2023 (version 1)
  5. Version of Record published: April 6, 2023 (version 2)

Copyright

© 2023, RInaldi et al.

This article is distributed under the terms of the Creative Commons Attribution License permitting unrestricted use and redistribution provided that the original author and source are credited.

Metrics

  • 1,641
    views
  • 219
    downloads
  • 2
    citations

Views, downloads and citations are aggregated across all versions of this paper published by eLife.

Download links

A two-part list of links to download the article, or parts of the article, in various formats.

Downloads (link to download the article as PDF)

Open citations (links to open the citations from this article in various online reference manager services)

Cite this article (links to download the citations from this article in formats compatible with various reference manager tools)

  1. Vera RInaldi
  2. Kathleen Messemer
  3. Kathleen Desevin
  4. Fengyun Sun
  5. Bethany C Berry
  6. Shweta Kukreja
  7. Andrew R Tapper
  8. Amy J Wagers
  9. Oliver J Rando
(2023)
Evidence for RNA or protein transport from somatic tissues to the male reproductive tract in mouse
eLife 12:e77733.
https://doi.org/10.7554/eLife.77733

Share this article

https://doi.org/10.7554/eLife.77733

Further reading

    1. Computational and Systems Biology
    2. Developmental Biology
    Gang Xue, Xiaoyi Zhang ... Zhiyuan Li
    Research Article

    Organisms utilize gene regulatory networks (GRN) to make fate decisions, but the regulatory mechanisms of transcription factors (TF) in GRNs are exceedingly intricate. A longstanding question in this field is how these tangled interactions synergistically contribute to decision-making procedures. To comprehensively understand the role of regulatory logic in cell fate decisions, we constructed a logic-incorporated GRN model and examined its behavior under two distinct driving forces (noise-driven and signal-driven). Under the noise-driven mode, we distilled the relationship among fate bias, regulatory logic, and noise profile. Under the signal-driven mode, we bridged regulatory logic and progression-accuracy trade-off, and uncovered distinctive trajectories of reprogramming influenced by logic motifs. In differentiation, we characterized a special logic-dependent priming stage by the solution landscape. Finally, we applied our findings to decipher three biological instances: hematopoiesis, embryogenesis, and trans-differentiation. Orthogonal to the classical analysis of expression profile, we harnessed noise patterns to construct the GRN corresponding to fate transition. Our work presents a generalizable framework for top-down fate-decision studies and a practical approach to the taxonomy of cell fate decisions.

    1. Developmental Biology
    2. Evolutionary Biology
    Zhuqing Wang, Yue Wang ... Wei Yan
    Research Article

    Despite rapid evolution across eutherian mammals, the X-linked MIR-506 family miRNAs are located in a region flanked by two highly conserved protein-coding genes (SLITRK2 and FMR1) on the X chromosome. Intriguingly, these miRNAs are predominantly expressed in the testis, suggesting a potential role in spermatogenesis and male fertility. Here, we report that the X-linked MIR-506 family miRNAs were derived from the MER91C DNA transposons. Selective inactivation of individual miRNAs or clusters caused no discernible defects, but simultaneous ablation of five clusters containing 19 members of the MIR-506 family led to reduced male fertility in mice. Despite normal sperm counts, motility, and morphology, the KO sperm were less competitive than wild-type sperm when subjected to a polyandrous mating scheme. Transcriptomic and bioinformatic analyses revealed that these X-linked MIR-506 family miRNAs, in addition to targeting a set of conserved genes, have more targets that are critical for spermatogenesis and embryonic development during evolution. Our data suggest that the MIR-506 family miRNAs function to enhance sperm competitiveness and reproductive fitness of the male by finetuning gene expression during spermatogenesis.